Nafarelin acetate for pituitary suppressions in in-vitro fertilisation cycles--a Singaporean experience.

AIM OF STUDY The aim of this prospective clinical trial was to determine if intranasal nafarelin acetate (NA) is as effective as leuprolide (LA), our standard GnRHa, in IVF cycles. In addition, we believe that this may be the first report of such a trial in an Asian IVF population. METHOD Midluteal GnRHa administration (LA = 0.5 mg/d; NA = 800 micrograms… CONTINUE READING